MarketsEconomic TimesJun 11, 2026· 1 min read
Goldman, Morgan Stanley Lead Investor Group in Lenskart Block Deal
A 2.3% stake in Lenskart worth Rs 1,960 crore was sold by Platinum Jasmine A 2018 Trust in a block deal, attracting major investors like Goldman Sachs and Morgan Stanley. The transaction reflects strong institutional confidence in the eyewear retailer's growth trajectory and the broader private market for consumer-tech companies.
A significant block deal in eyewear retailer Lenskart has seen the sale of a 2.3% stake by ADIA-backed Platinum Jasmine A 2018 Trust for approximately Rs 1,960 crore. The transaction drew substantial interest from a diverse group of institutional investors, including global financial giants Goldman Sachs and Morgan Stanley.
This divestment activity highlights ongoing capital market movements within India's retail sector, particularly for companies demonstrating strong growth narratives. The involvement of major foreign investors, alongside domestic mutual funds and insurers, signals continued confidence in Lenskart's business model and its potential for market expansion within the competitive eyewear segment. Such block deals often provide liquidity for early investors while allowing new institutional capital to enter, potentially bolstering the company's valuation and future strategic options.
The participation of prominent investment banks and other financial institutions underscores a broader trend of private market assets attracting significant institutional flows, even as public markets navigate various macroeconomic headwinds. The transaction's scale, at nearly 20 billion Indian rupees, also reflects a material reallocation of capital, indicative of sustained investor appetite for established, growth-oriented companies in consumption-driven sectors.
Analyst's Take
While a positive signal for Lenskart and the Indian consumer market, this transaction subtly indicates a potential shift in liquidity preferences for private equity firms. The divestment by ADIA-backed Platinum Jasmine may precede further secondary market activity for other portfolio companies, as long-term investors seek to realize returns amidst a more cautious IPO environment, thus offering opportunities for new institutional capital to gain exposure to pre-IPO assets at potentially more attractive valuations than would be seen in a robust IPO window.
